01 10Pfizer Canada ULC
01 52732797
02 52814581
01 10TALAZOPARIB TOSYLATE
01 10CAPSULE
01 31931-10-20
02 52029-07-27
03 22031-10-20
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Brand Name : TALZENNA
Patent Number : 2732797
Filing Date : 2009-07-27
Strength per Unit : 0.35 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Patent Expiration Date : 1931-10-20
Date Granted : 2019-02-12
Brand Name : TALZENNA
Patent Number : 2814581
Filing Date : 2011-10-20
Strength per Unit : 0.35 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1931-10-20
Date Granted : 2019-02-12
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Brand Name : TALZENNA
Patent Number : 2732797
Filing Date : 2009-07-27
Strength per Unit : 0.5 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Patent Expiration Date : 1931-10-20
Date Granted : 2019-02-12
Brand Name : TALZENNA
Patent Number : 2814581
Filing Date : 2011-10-20
Strength per Unit : 0.5 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1931-10-20
Date Granted : 2019-02-12
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Brand Name : TALZENNA
Patent Number : 2732797
Filing Date : 2009-07-27
Strength per Unit : 0.1 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Patent Expiration Date : 1931-10-20
Date Granted : 2019-02-12
Brand Name : TALZENNA
Patent Number : 2814581
Filing Date : 2011-10-20
Strength per Unit : 0.1 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1931-10-20
Date Granted : 2019-02-12
Patent Expiration Date : 2031-10-20
Date Granted : 2019-02-12
Brand Name : TALZENNA
Patent Number : 2814581
Filing Date : 2011-10-20
Strength per Unit : 0.25 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-10-20
Date Granted : 2019-02-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Brand Name : TALZENNA
Patent Number : 2732797
Filing Date : 2009-07-27
Strength per Unit : 0.25 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-10-20
Date Granted : 2019-02-12
Brand Name : TALZENNA
Patent Number : 2814581
Filing Date : 2011-10-20
Strength per Unit : 1 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-10-20
Date Granted : 2019-02-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Brand Name : TALZENNA
Patent Number : 2732797
Filing Date : 2009-07-27
Strength per Unit : 1 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-07-27
Date Granted : 2017-01-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
